NCT06677203 - Study of ASN51 in Adults With Early Alzheimer's Disease | Biotech Hunter

Enrollment

123

Participants

Timeline

Start Date

October 16, 2024

Primary Completion Date

November 8, 2024

Study Completion Date

November 8, 2024

Conditions

Alzheimer Disease

Interventions

DRUG

ASN51

Oral capsules

DRUG

Placebo

Oral capsules

Trial Locations (7)

Re:Cognition Health, Fairfax

Columbus Memory Center, LLC, Columbus

K2 Medical Research - The Villages, Lady Lake

K2 Medical Research, Maitland

Alzheimer's Treatment and Research Center, Wellington

K2 Medical Research, Clermont

Alzheimer's Treatment and Research Center, Stuart